Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

PMID:
25378467
2.

Mid-term follow-up after maze IV procedures for concomitant atrial fibrillation.

Ballaux PK, Cathenis KK, Brondeel R, Provenier FP, Francois BA, Goossens DJ, Hamerlijnck RP.

Acta Chir Belg. 2014 Mar-Apr;114(2):99-104.

PMID:
25073206
3.

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators.

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.

4.

Unforeseen consequences of device-device interaction.

Buyssens T, Provenier F.

Pacing Clin Electrophysiol. 2015 Apr;38(4):526-8. doi: 10.1111/pace.12397. Epub 2014 Apr 2. No abstract available.

PMID:
24697799
5.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
6.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators.

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.

PMID:
22402056
7.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

8.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

9.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

10.

Prevalence of potential cardiac resynchronization therapy candidates and actual use of cardiac resynchronization therapy in patients hospitalized for heart failure.

De Sutter J, Weytjens C, Van de Veire N, Provenier F, Vande Kerckhove B, Willems AM, De Laet N, Van Camp G.

Eur J Heart Fail. 2011 Apr;13(4):412-5. doi: 10.1093/eurjhf/hfq217. Epub 2010 Dec 7. No abstract available.

PMID:
21138909
11.

Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular cardiomyopathy.

Lochy S, François B, Hollanders G, Provenier F.

Europace. 2010 Aug;12(8):1195-6. doi: 10.1093/europace/euq091. Epub 2010 Mar 27.

12.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

13.

Silent lead malfunction detected only during defibrillator replacement.

Stroobandt R, Hagers Y, Provenier F, VAN Belle Y, Hamerlijnck R, Barold SS.

Pacing Clin Electrophysiol. 2006 Jan;29(1):67-9. No abstract available.

PMID:
16441721
14.

Improved differentiation of the ventricular evoked response from polarization by modification of the pacemaker impulse.

Provenier F, Germonpré E, De Wagter X.

Pacing Clin Electrophysiol. 2000 Dec;23(12):2073-7.

PMID:
11202250
15.
16.

Low-energy intracardiac shocks during atrial fibrillation: effects on cardiac rhythm.

Gjorgov N, Provenier F, Jordaens L.

Am Heart J. 1997 Jan;133(1):101-7.

PMID:
9006297
17.

A randomized, single-blind crossover comparison of the effects of chronic DDD and dual sensor VVIR pacing mode on quality-of-life and cardiopulmonary performance in complete heart block.

Deharo JC, Badier M, Thirion X, Ritter P, Provenier F, Graux P, Guillot C, Mugica J, Jordaens L, Djiane P.

Pacing Clin Electrophysiol. 1996 Sep;19(9):1320-6.

PMID:
8880795
18.

A new transvenous internal cardioverter-defibrillator: implantation technique, complications, and short-term follow-up.

Jordaens L, Vertongen P, Provenier F, Trouerbach JW, Poelaert J, Herregods L.

Am Heart J. 1995 Feb;129(2):251-8.

PMID:
7832096
19.

The "automatic mode switch" function in successive generations of minute ventilation sensing dual chamber rate responsive pacemakers.

Provenier F, Jordaens L, Verstraeten T, Clement DL.

Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 2):1913-9.

PMID:
7845791
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk